Free shipping
ON ALL ORDERS ABOVE $199 (On Cart Value)Cytoblastin 10 mg Injection
$12.00 – $32.00

Cytoblastin 10 mg Injection | ||||
---|---|---|---|---|
Pack Size | Price | Price/Unit | Quantity | |
1 Injection/s | $12.00 | $12.00 /Piece | Out Of Stock | |
2 Injection/s | $23.00 | $11.50 /Piece | Out Of Stock | |
3 Injection/s | $32.00 | $10.67 /Piece | Out Of Stock |
- Description
- Additional information
- Product Tag
- Reviews (0)
Description
Cytoblastin 10 mg Injection (Vinblastine Sulphate)
Buy Cytoblastin 10 mg Injection (Vinblastine Sulphate)is used in the treatment of breast cancer, kidney cancer, Hodgkin’s diseaseand Non-Hodgkin’s lymphoma.
Vinblastine Sulphate blocks replication of genetic material (DNA) in the cancer cells. Thus it stops the growth and multiplication of cancer cells.
Your doctor or nurse will give you this medicine. Kindly do not self administer.
Side Effects of Vinblastine Sulphate are Nausea, Vomiting, Decreased appetite, Decreased white blood cell count, Diarrhoea.
In males Vinblastine Sulphate may cause aspermia (lack of semen causing infertility); in females vinblastine may cause amenorrhea (absence of menstruation), which may recover after some duration.
Take precautions while taking vinblastine as it may cause inflammation of mouth and lips (stomatitis) and neurological toxicity.
Avoid even accidental contamination of eyes with Vinblastine Sulphate, as it may cause severe irritation.
Vinblastine may cause acute kidney disease (nephropathy) related to uric acid level.
Tell your doctor if you are or planning to become pregnant or are breastfeeding.
Additional information
Country of Origin | India |
---|---|
Dosage Form | Injection |
Equivalent Brand | Vinblastin |
Generic Name | Vinblastine Sulphate |
Indication | Breast cancer, Kidney cancer, Hodgkin’s disease |
Manufacturer | Cipla Ltd |
Packaging | 10 ml in 1 vial |
Composition | Vinblastine Sulphate (10mg) |
Be the first to review “Cytoblastin 10 mg Injection”
You must be logged in to post a review.
Reviews
There are no reviews yet.